Cardiac autonomic and ventricular mechanical functions in asymptomatic chronic chagasic cardiomyopathy

Daniel França Vasconcelos1, Luiz Fernando Junqueira

  • 1Laboratório Cardiovascular, Faculdade de Medicina, Universidade de Brasília, DF, Brasil. dfrancav@cardiol.br

Insights

Cardiac autonomic dysfunction in Chagas disease appears to precede ventricular issues, with reduced sympathetic and parasympathetic activity observed. This autonomic alteration may occur independently of mechanical heart changes in asymptomatic patients.

Area of Science:

  • Cardiology
  • Autonomic Nervous System Research
  • Chagas Disease Research

Background:

  • Chronic Chagas disease can affect cardiac function, but the interplay between autonomic control and ventricular mechanics is not well understood.
  • Previous research on cardiac autonomic and ventricular function in Chagas disease has yielded controversial and limited findings.

Purpose of the Study:

  • To assess cardiac autonomic and ventricular mechanical function alterations in asymptomatic Chagasic cardiomyopathy.
  • To investigate potential associations between autonomic and ventricular dysfunction in this patient group.

Main Methods:

  • Evaluated 13 asymptomatic Chagasic cardiomyopathy patients and 15 controls.
  • Assessed heart rate variability (autonomic modulation) in temporal and spectral domains, in supine and orthostatic positions.
  • Correlated autonomic function with Doppler echocardiography-derived ventricular function parameters.

Main Results:

  • Chagasic patients exhibited lower temporal and spectral heart rate variability indices, indicating autonomic dysfunction.
  • No significant differences in most echocardiographic variables were found between groups.
  • A larger left ventricular end-systolic diameter in Chagasic patients correlated with reduced global and parasympathetic autonomic modulation in the orthostatic position.

Conclusions:

  • Sympathetic and parasympathetic function were depressed in Chagasic patients, but their balance was preserved.
  • Autonomic dysfunction was linked to only one indicator of ventricular dysfunction.
  • Cardiac autonomic dysfunction may precede and be independent of ventricular dysfunction in chronic Chagasic cardiomyopathy.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...